Succeeding in the Shadow of the Oracle-Phase Forward Acquisition

By Dr. Alan S. Louie – April 19, 2010
Photo of Dr. Alan S. LouieOffline

I have long argued that clinical development has been moving in the direction of comprehensive eClinical solutions that enable transparent sharing of data and more efficient production of information.  The recent acquisition of Phase Forward by Oracle is a significant milestone in the shift towards that goal.  In discussion with numerous trial sponsors regarding their selection of particular eClinical applications (e.g. EDC, CDMS, CTMS, IVRS, ePRO, Drug Safety, etc.), there has been only fleeting


About the author

Dr. Alan S. Louie

Research DirectorIDC Health Insights

Dr. Alan Louie is Research Director at IDC Health Insights. In this role, he is spearheading the company’s research covering innovation and best practices in pharmaceutical R&D and personalized…


Post a comment

Form Signatures

Viewed 1,239 times